KAYO MOTOR
834058
Zhejiang Zoenn Design
300901
Zhejiang Meorient Commerce & Exhibition Inc.
300795
Fujian Zitian Media Technology
300280
Zhejiang Prulde Electric Appliance
301353
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | 30.88%843.16M | 90.31%2.03B | 61.21%1.17B | -9.55%993.77M | -43.49%644.21M | -46.26%1.07B | -65.07%726.15M | 58.64%1.1B | -29.86%1.14B | 58.41%1.98B |
Transactional financial assets | -30.53%1.78B | -31.28%1.63B | 11.36%3.15B | -10.74%2.11B | 3.51%2.56B | -18.52%2.37B | 1.83%2.83B | -10.90%2.37B | -17.09%2.47B | 8.84%2.9B |
Notes receivable and accounts receivable | -9.71%2.37B | 17.72%1.75B | 1.45%2.1B | 2.87%2.3B | -4.43%2.62B | -41.75%1.49B | 14.18%2.07B | 21.93%2.23B | 28.08%2.74B | 136.67%2.55B |
-Accounts receivable | -9.71%2.37B | 17.72%1.75B | 1.45%2.1B | 2.87%2.3B | -4.43%2.62B | -41.75%1.49B | 14.18%2.07B | 21.93%2.23B | 28.08%2.74B | 136.67%2.55B |
Other receivables (including interest and dividends) | 126.15%16.57M | 82.51%16.58M | 123.23%18.86M | 41.63%6.6M | 22.83%7.33M | 59.92%9.09M | -31.76%8.45M | 8.58%4.66M | -66.31%5.96M | -49.95%5.68M |
-Other receivable | ---- | 82.51%16.58M | ---- | ---- | ---- | 59.92%9.09M | ---- | 8.58%4.66M | ---- | -39.37%5.68M |
Advance payment | 63.83%68.1M | 114.84%71.66M | 67.67%58.85M | 13.73%33.53M | 2.48%41.57M | -47.47%33.35M | -69.13%35.1M | -19.61%29.48M | -36.19%40.56M | 12.09%63.49M |
Inventories | 11.82%1.91B | 6.86%1.92B | 17.31%1.92B | 15.69%1.67B | 8.21%1.7B | 13.76%1.8B | -1.79%1.64B | 6.47%1.45B | 9.67%1.58B | 5.07%1.58B |
Receivable financing | 9.73%145.78M | 274.94%211.1M | 110.91%143.69M | 65.01%293.91M | -42.45%132.86M | -62.30%56.3M | -31.55%68.13M | -33.18%178.11M | 22.09%230.86M | -24.56%149.33M |
Assets held for sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --132.08M | ---- | ---- |
Non-current assets due within one year | 130.59%2.05B | 50.99%1.33B | 177.27%1.14B | 405.61%1.21B | --888.98M | --882.85M | --410M | --240M | ---- | ---- |
Other current assets | 7,608.97%90.09M | 237.74%60.06M | 56,973.79%151.81M | 102.29%701.17M | 665.41%1.17M | 6,549.14%17.78M | -90.21%265.99K | 12,454.88%346.61M | -94.68%152.69K | -90.93%267.47K |
Total current assets | 7.70%9.27B | 16.86%9.02B | 26.55%9.86B | 15.47%9.33B | 4.79%8.6B | -16.48%7.72B | -9.11%7.79B | 17.90%8.08B | -2.96%8.21B | 36.42%9.24B |
Non Current assets | ||||||||||
Long-term equity investment | -81.21%6.03M | -64.00%12.99M | -51.79%21.52M | -62.24%26.44M | -57.43%32.12M | -55.84%36.09M | -48.26%44.64M | -27.39%70.02M | -28.85%75.44M | -16.69%81.72M |
Fixed assets | ---- | 0.71%2.08B | ---- | ---- | ---- | -7.88%2.07B | ---- | -6.36%2.06B | ---- | 55.78%2.24B |
Constru in process | ---- | 190.20%705.12M | ---- | ---- | ---- | 92.60%242.98M | ---- | 62.75%216.39M | ---- | -75.62%126.15M |
Productive biological assets | -45.45%856.33K | ---- | 54.95%367.15K | 49.03%965.1K | 16.26%1.57M | -45.48%349K | -60.08%236.94K | -58.70%647.59K | -46.79%1.35M | 0.79%640.15K |
Intangible assets | -0.41%315.93M | -0.95%318.96M | 4.37%321.83M | 3.13%319.72M | 1.10%317.23M | 1.81%322.01M | 49.90%308.35M | 51.57%310M | 51.95%313.79M | 64.05%316.28M |
Development expenditure | 7.23%27.64M | 9.68%27.44M | 10.87%26.92M | 8.71%26.27M | 7.59%25.77M | 7.70%25.02M | 5.55%24.28M | 7.27%24.16M | 7.97%23.95M | 6.01%23.23M |
Goodwill | ---- | ---- | 0.00%1.1M | 0.00%1.1M | 0.00%1.1M | 0.00%1.1M | 0.00%1.1M | 0.00%1.1M | 0.00%1.1M | 0.00%1.1M |
Long deferred expense | 22.97%30M | 25.67%32.7M | 120.78%34.6M | 81.85%33.33M | 1.57%24.4M | 2.80%26.02M | -49.01%15.67M | -44.27%18.33M | -34.20%24.02M | -3.96%25.31M |
Deferred tax assets | -11.51%207.86M | 6.74%242.47M | 0.87%228.28M | 3.97%241.72M | 8.07%234.89M | 4.59%227.16M | 8.90%226.31M | 15.52%232.49M | 17.01%217.34M | 6.72%217.19M |
Usufruct assets | -3.96%9.26M | -3.76%9.41M | -5.29%9.39M | -5.36%9.52M | 24,011.61%9.64M | 17,669.52%9.77M | 14,059.76%9.91M | 11,729.92%10.06M | --40K | --55K |
Other non current assets | -10.40%3.41B | -16.49%3.19B | -31.53%3B | -8.50%3.4B | 12.87%3.8B | 63.00%3.82B | 69.90%4.38B | 107.83%3.72B | 942.30%3.37B | 802.33%2.34B |
Total non current assets | -1.33%6.84B | -2.31%6.62B | -12.07%6.41B | 1.70%6.78B | 8.59%6.93B | 26.00%6.78B | 34.38%7.29B | 42.24%6.67B | 119.12%6.38B | 94.76%5.38B |
Total assets | 3.67%16.1B | 7.90%15.64B | 7.87%16.27B | 9.24%16.11B | 6.45%15.53B | -0.85%14.49B | 7.75%15.08B | 27.79%14.74B | 28.30%14.59B | 53.32%14.62B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | 0.00%600M | 12.50%900M | 0.00%800M | -12.50%700.35M | 0.00%600M | -27.27%800M | 0.00%800M | -0.04%800.38M | -45.45%600M | 266.67%1.1B |
Notes payable and accounts payable | -0.54%204.66M | 0.48%210.36M | 14.78%244.12M | 12.41%197.26M | -48.37%205.77M | -10.02%209.35M | -36.81%212.68M | -27.19%175.49M | 107.16%398.56M | 23.02%232.65M |
-Notes payable | 120.68%6.91M | -35.10%12.01M | 97.21%19.86M | ---- | -98.58%3.13M | 101.66%18.51M | -81.50%10.07M | -36.61%15.31M | 563.71%220.18M | -84.28%9.18M |
-Accounts payable | -2.41%197.75M | 3.94%198.34M | 10.68%224.26M | 23.15%197.26M | 13.60%202.64M | -14.60%190.83M | -28.19%202.61M | -26.14%160.17M | 12.04%178.38M | 70.94%223.47M |
Contract liabilities | -11.83%9.79M | 101.94%19.2M | -10.36%10.14M | -42.01%8.57M | 39.26%11.11M | -13.09%9.51M | 139.87%11.31M | 78.65%14.78M | 87.23%7.98M | 82.01%10.94M |
Advance receipts | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --12.6K | ---- |
Salaries payable | -57.48%514.7K | -71.54%136.39K | 20.45%492.93K | 39.18%27.89K | 180.63%1.21M | 405.13%479.22K | 25.89%409.25K | -99.52%20.04K | -90.63%431.38K | -97.80%94.87K |
Taxs payable | -50.37%72.19M | -11.99%35.67M | -49.30%24.53M | 145.07%87.75M | 48.52%145.47M | -73.50%40.52M | -26.43%48.38M | -55.46%35.81M | -31.63%97.94M | 126.50%152.92M |
Other payable (including interest and dividends) | -0.08%1.25B | 21.13%1.02B | 5.72%1.08B | 14.80%1.29B | 4.88%1.25B | -31.00%840.11M | 9.86%1.02B | 4.77%1.12B | 11.40%1.2B | 45.50%1.22B |
-Dividend payable | --93.32M | --93.32M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --6.75M |
-Other payable | ---- | 10.02%924.3M | ---- | ---- | ---- | -30.62%840.11M | ---- | 5.17%1.12B | ---- | 44.70%1.21B |
Non current liabilities due within one year | 24,357.32%150.76M | 62,880.98%150.76M | 127,194.94%300M | 68,345.11%300.36M | -95.89%616.43K | -98.40%239.38K | -97.64%235.67K | -95.69%438.83K | --15M | --15M |
Other current liabilities | -11.84%293.7K | 102.01%575.87K | -10.37%304K | -41.97%257.11K | 39.81%333.16K | -12.18%285.07K | 139.90%339.16K | 78.83%443.03K | 86.55%238.3K | 81.92%324.6K |
Total current liabilities | 3.28%2.29B | 22.83%2.33B | 17.40%2.46B | 20.16%2.58B | -4.21%2.22B | -30.37%1.9B | -2.44%2.1B | -3.01%2.15B | -8.03%2.32B | 94.42%2.73B |
Current liabilities | ||||||||||
Long term loan | ---- | ---- | ---- | ---- | 66.67%300M | 66.67%300M | 57.89%300M | 57.89%300M | --180M | --180M |
Deferred tax liabilities | 32.52%44.74M | 35.73%40.82M | 85.82%41.36M | 105.15%42.82M | 129.72%33.76M | 123.76%30.07M | 15.58%22.26M | 101.28%20.87M | 150.32%14.7M | -30.11%13.44M |
Long term deferred income | -11.58%46.46M | -7.08%48.09M | -6.46%49.63M | -5.87%51.18M | -7.40%52.54M | -6.69%51.75M | -8.11%53.06M | -6.11%54.37M | 8.38%56.74M | 5.94%55.46M |
Lease liabilities | -4.25%8.67M | -11.76%8.57M | -3.96%9.23M | -1.60%9.15M | --9.06M | --9.71M | --9.61M | --9.3M | ---- | ---- |
Total non current liabilities | -74.74%99.87M | -75.11%97.47M | -73.96%100.22M | -73.18%103.15M | 57.24%395.36M | 57.30%391.53M | 44.17%384.93M | 48.89%384.54M | 331.83%251.44M | 247.70%248.9M |
Total liabilities | -8.53%2.39B | 6.10%2.43B | 3.22%2.56B | 5.99%2.68B | 1.81%2.61B | -23.05%2.29B | 2.71%2.48B | 2.41%2.53B | -0.35%2.57B | 101.86%2.98B |
Shareholders equity | ||||||||||
Paid-in capital | 0.24%1.83B | 0.24%1.83B | 0.24%1.83B | 0.24%1.83B | 0.00%1.82B | 0.00%1.82B | 0.00%1.82B | 0.00%1.82B | 0.00%1.82B | 0.00%1.82B |
Capital reserve funds | 1.19%1.45B | 4.08%1.48B | 5.34%1.5B | 4.97%1.49B | 1.40%1.43B | 1.05%1.42B | 0.70%1.42B | 1,239.92%1.42B | 1,246.75%1.41B | 1,258.62%1.41B |
Surplus reserve funds | 9.31%806.81M | 9.31%806.81M | 9.31%806.81M | 9.31%806.81M | 8.82%738.08M | 8.82%738.08M | 8.82%738.08M | 8.82%738.08M | 19.35%678.23M | 19.35%678.23M |
Retained profit | 10.38%7.66B | 12.15%7.18B | 11.45%7.55B | 13.48%7.29B | 10.08%6.94B | 6.89%6.4B | 12.82%6.77B | 11.29%6.42B | 11.85%6.31B | 18.85%5.99B |
Less:Treasury stock | --46.75M | --46.75M | --48.07M | --48.07M | ---- | ---- | ---- | ---- | ---- | ---- |
Shareholders equity without minority interests | 6.99%11.7B | 8.30%11.25B | 8.15%11.63B | 9.24%11.36B | 7.00%10.93B | 4.92%10.39B | 8.49%10.76B | 24.73%10.4B | 26.24%10.22B | 32.12%9.9B |
Minority interests | 1.46%2.01B | 7.87%1.96B | 12.53%2.08B | 13.78%2.06B | 9.94%1.99B | 4.32%1.81B | 10.70%1.85B | 149.22%1.81B | 157.02%1.81B | 207.93%1.74B |
Total shareholder equity | 6.14%13.71B | 8.24%13.21B | 8.79%13.71B | 9.92%13.42B | 7.44%12.92B | 4.83%12.2B | 8.81%12.6B | 34.71%12.21B | 36.68%12.02B | 44.43%11.64B |
Total liabilityies and equity | 3.67%16.1B | 7.90%15.64B | 7.87%16.27B | 9.24%16.11B | 6.45%15.53B | -0.85%14.49B | 7.75%15.08B | 27.79%14.74B | 28.30%14.59B | 53.32%14.62B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
Auditor | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.